ROLE OF PRIMARY CHEMOTHERAPY IN STAGE I AND LOW-VOLUME STAGE II NONSEMINOMATOUS GERM-CELL TESTIS TUMORS-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ROLE OF PRIMARY CHEMOTHERAPY IN STAGE I AND LOW-VOLUME STAGE II NONSEMINOMATOUS GERM-CELL TESTIS TUMORS

Published:1993-02 Issue:1 Volume:20 Page:93-109
ISSN:0094-0143
Container-title:Urologic Clinics of North America
language:en
Short-container-title:Urologic Clinics of North America

Author:

Sternberg Cora N.

Publisher

Elsevier BV

Subject

Urology

Reference88 articles.

1. Is routine primary retroperitoneal lymph node dissection still justified in patients with low stage non-seminomatous testicular cancer?;Aass;Br J Urol,1990

2. Triple drug therapy in testicular tumors;Ansfield;Cancer,1969

3. Selected experience with surgery and combination chemotherapy in the treatment of nonseminomatous testis tumors;Braedel;J Urol,1983

4. Sexual function and fecundity after treatment for testicular tumors;Braken;Urology,1976

5. Safety of surveillance in the management of stage I anaplastic germ cell tumours of the testis;Crawford;Br J Urol,1988

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retroperitoneal lymph node dissection after chemotherapy for germ cell tumours: is a full bilateral template always necessary?;BJU International;2008-08

2. Two cycles of cisplatin-based chemotherapy for low-volume retroperitoneal stage II nonseminomatous germ cell tumours;BJU International;2006-08

3. Long-term results of laparoscopic retroperitoneal lymph node dissection: a single-center 10-year experience;Urology;2004-03

4. Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis;Urology;2004-01

5. A Population-based Analysis of Increased Incidence and Improved Survival of Testicular Cancer Patients in Iceland;Scandinavian Journal of Urology and Nephrology;2003-01-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3